Safety of Single Doses of CSL889 in Adult Patients With Sickle Cell Disease

Jacobi Medical Center, The Bronx

UPMC Hillman Cancer Center, Pittsburgh

The Johns Hopkins Hospital, Baltimore

Brody School of Medicine at East Carolina University, Greenville

Medical University of South Carolina, Charleston

Ohio State University, Columbus

University of Minnesota, Minneapolis

University of Illinois Hospital and Health Science Systems, Chicago

Amsterdam UMC Academic Medical Center, Amsterdam

Erasmus University Medical Center, Rotterdam

Liverpool University Hospital, Liverpool

Guys and St. Thomas, London

University College London Hospital, London

Early Phase Unit, Manchester

Manchester University Hospitals NHS Foundation Trust / Manchester Royal Infirmary, Manchester